UniProt ID | Protein Name ▼ | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7L1QJI6 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1QXQ7 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1QTC8 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1R8M8 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7L1QEM0 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7L1QUJ0 | RET kinase (Fragment) |
|
1 | 0 |
|
A0A7L1R350 | Protein adenylyltransferase FICD (Fragment) |
|
1 | 0 |
|
A0A7L1QAR7 | Potassium channel subfamily K member 1 (Fragment) |
|
1 | 0 |
|
A0A7L1QBD1 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L1R8Y8 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L1QIF6 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L1QHS1 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A7L1QJ30 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A7L1QKX2 | NOGG protein (Fragment) |
|
1 | 0 |
|
A0A7L1QXE3 | N-acetylgalactosamine-6-sulfatase (Fragment) |
|
1 | 0 |
|
A0A7L1R0R6 | KCNKG protein (Fragment) |
|
1 | 0 |
|
A0A7L1QPQ5 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1QBP2 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1QME5 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1QDM5 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1R0Y9 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1QXX5 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1QWZ0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1R5L3 | Fibroblast growth factor receptor 2 (Fragment) |
|
8 | 0 |
|
A0A7L1QJC7 | Fibroblast growth factor receptor 1 (Fragment) |
|
8 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024